Access to medications is a vital aspect of maintaining healthy lives, and the urge to invest in personal health has only grown since the COVID-19 pandemic.
The COVID-19 pandemic has highlighted the importance of ensuring a reliable supply of treatments across the globe at pace and speed. Jirair Ratevosian, executive director of global patient
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.